NumerixS Investment Technologies’s TherapeuticsMD TXMD Stock Holding History

NumerixS Investment Technologies’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-630	Closed	-$76K	–	1283
2019 Q4	$76K	Buy	+630	New	+$90.6K	0.02%	738
2019 Q3	–	Sell	-502	Closed	-$65K	–	1234
2019 Q2	$65K	Buy	+502	New	+$90K	0.02%	716
2018 Q4	–	Sell	-272	Closed	-$90K	–	1379
2018 Q3	$90K	Sell	272 -381	-58%	-$117K	0.02%	833
2018 Q2	$218K	Buy	+653	New	+$199K	0.05%	496
2018 Q1	–	Sell	-2	Closed	-$1K	–	1289
2017 Q4	$1K	Buy	+2	New	+$557	﹤0.01%	1095
2016 Q4	–	Sell	-1,300	Closed	-$443K	–	1339
2016 Q3	$443K	Buy	1,300 +78	+6%	+$28.5K	0.06%	412
2016 Q2	$519K	Buy	+1,222	New	+$504K	0.07%	381

Other funds holding TXMD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NumerixS Investment Technologies's TXMD Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of TherapeuticsMD (TXMD) in Q1 2020, closing a stake of 630 shares — an estimated $76K sold.

NumerixS Investment Technologies first reported a position in TXMD in Q2 2016 and held it in 7 quarters. The position peaked at $519K in Q2 2016. 143 funds tracked by Wall St. Rank hold TXMD as of Q1 2020.

NumerixS Investment Technologies reported no remaining TherapeuticsMD position as of Q1 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 630 TherapeuticsMD shares in Q1 2020, an estimated $76K.
NumerixS Investment Technologies first reported a position in TherapeuticsMD in Q2 2016 and held it in 7 quarters.
NumerixS Investment Technologies's TherapeuticsMD position peaked at $519K in Q2 2016.
143 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.